Company profile for Sciwind Biosciences

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Sciwind Biosciences is rapidly emerging as a leading clinical-stage biopharmaceutical company with a clear focus on the exploration and advancement of innovative therapies for the treatment of metabolic diseases. At Sciwind, our dedication lies in the discovery and development of novel therapeutics aimed at halting and even reversing the progression of metabolic disorders, ultimately enhancing the well-being of patients global...
Sciwind Biosciences is rapidly emerging as a leading clinical-stage biopharmaceutical company with a clear focus on the exploration and advancement of innovative therapies for the treatment of metabolic diseases. At Sciwind, our dedication lies in the discovery and development of novel therapeutics aimed at halting and even reversing the progression of metabolic disorders, ultimately enhancing the well-being of patients globally.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
China
Address
Address
Qiantang New District Hangzhou, Zhejiang
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/sciwind-biosciences-announces-global-licensing-and-collaboration-agreement-for-metabolic-disease-portfolio-302347773.html

PR NEWSWIRE
10 Jan 2025

https://www.prnewswire.com/news-releases/sciwind-biosciences-announces-oral-presentation-on-oral-glp-2-research-progress-at-the-32nd-united-european-gastroenterology-week-ueg-week-2024-302261785.html

PR NEWSWIRE
07 Oct 2024

https://www.prnewswire.com/news-releases/sciwind-biosciences-announces-oral-presentations-at-the-european-association-for-the-study-of-diabetes-60th-annual-meeting-easd-2024-302240167.html

PR NEWSWIRE
05 Sep 2024

https://www.prnewswire.com/news-releases/sciwind-biosciences-to-highlight-positive-results-for-injectable-ecnoglutide-phase-3-oral-ecnoglutide-phase-1-and-novel-amylin-analogs-at-the-american-diabetes-association-ada-84th-annual-conference-302178846.html

PR NEWSWIRE
21 Jun 2024

https://www.prnewswire.com/news-releases/sciwind-biosciences-announces-positive-results-from-phase-1-clinical-trial-of-xw004-an-oral-formulation-of-long-acting-glp-1-analog-ecnoglutide-302042633.html

PR NEWSWIRE
23 Jan 2024
Sciwind posts pivotal data on Chinese GLP-1 rival to Novo, Lilly
Sciwind posts pivotal data on Chinese GLP-1 rival to Novo, Lilly

03 Jan 2024

// Nick Paul Taylor FIERCE BIOTECH

https://www.fiercebiotech.com/biotech/sciwind-blows-glp-1-contention-pivotal-data-chinese-rival-novo-lilly

Nick Paul Taylor FIERCE BIOTECH
03 Jan 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty